Centers for Disease Control and Prevention (CDC) — 2018 Investments
11 investments dated 2018 · listed companies and verified rows first · show all
Gaia Medical Institute develops BrainGuardian, a rapid saliva-based test that detects concussions and traumatic brain injury using novel cellular biomarkers, intended for use at sidelines, schools, homes, and clinics rather than hospitals.
BiotechHealthtechMedical Devices
HDT Bio develops immunotherapy technologies, including its LION formulation platform, designed to activate the immune system against difficult-to-treat conditions.
BiotechHealthtech
TeleSage provides web-based behavioral health screenings and assessments—including the DSM-5-based DISC for children/adolescents and the SCID-5 structured clinical interview—that can be administered on any device and generate instant differential diagnosis reports.
Digital HealthHealthtechMental Health
MDLogix offers bhworks, a platform for schools and states that unifies six modules — behavioral and mental health, nursing, universal screening, attendance/truancy, Medicaid billing, and special education/IEP — under a single Multi-Tiered System of Supports framework.
Digital HealthEdTechMental Health
Redwood City, US
Matthew Tamayo-Rios(Executive Officer, Director)Patrick Grady(Director)
BoardRon Bouganim(Director)
Tria Bioscience develops diagnostic and assistive technologies for hearing assessment, hearing aids, and cochlear implants.
Deep TechHealthtechMedical Devices
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.